Heart Guard
Natural health product licensed in Canada
- Licence holder
- Natural Factors Nutritional Products Limited
- NPN or DIN-HM
- 80124726
- Status
- Active licence
- Licence date
- 1 June 2023
- Revision date
- 15 June 2023
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 350 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 350 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Folate Source : Acide folique | 500 Microgrammes | Not calculated |
| Magnésium Source : Citrate de magnésium | 175 mg | 350,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 0.8 mg | 1,600 µg |
| Vitamine B12 Source : Méthylcobalamine | 62.5 Microgrammes | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 15 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Rhodobacter sphaeroides - Whole | 15 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 12.5 Microgrammes | Not calculated |
| Vitamine D Source : Cholécalciférol | 500 UI | 25 µg |
| Vitamine C Source : Acide ascorbique | 50 mg | 100,000 µg |
| Vitamine K2 Source : Ménaquinone 7 | 60 Microgrammes | Not calculated |
| 3-[[6-O-(6-désoxy-alpha-L-mannopyranosyl)-bêta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphényl)-5,7-dihydroxy-4H-1-benzopyran-4-one Source : Rutine | 200 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylcellulose, NA, Phosphate de dicalcium dihydraté, Stéarate de magnésium, Glycérine, Acide stéarique, Silice, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Provides) An antioxidant. Used in Herbal Medicine as a capillary/blood vessel protectant. A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps in bone development. Helps in collagen formation (to maintain/support healthy bones/cartilage/teeth/(and) gums). Helps in energy metabolism/(and) tissue formation. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones/cartilage/teeth/(and) gums. Helps in the maintenance of bones. Helps in wound healing/(and) connective tissue formation. Helps to build strong bones/(and) teeth. Helps to form red blood cells. Helps to maintain/support healthy metabolism. Helps to maintain/support heart muscle function. Helps to maintain/support immune function/the immune system. Helps to maintain/support normal electrolyte balance. Helps to maintain/support normal muscle function, including the heart muscle. Helps to maintain/support normal muscle function. Helps to maintain/support the body's ability to metabolize nutrients. Helps to prevent folate deficiency. Helps to prevent vitamin B12 deficiency. Helps to prevent vitamin D deficiency. Helps to prevent vitamin K deficiency. Helps with immune function/the immune system. Maintains/supports good health. Source of/Provides (an) antioxidant(s) for the maintenance of good health. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/Provides (an) electrolyte(s) for the maintenance of good health. Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Vitamin and mineral supplement. Helps to maintain and/or support cardiovascular health. Source of vitamins and mineral to support biological functions which play a key role in the maintenance of good health. Source of vitamins and mineral, factors in normal growth and development. Source of vitamins and mineral, factors in the maintenance of good health. Helps to reduce homocysteine levels in the body for the maintenance of good health. Elevated blood homocysteine levels have been linked to an increased risk of cardiovascular disease.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80124726
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging